JPMorgan cuts BellRing Brands stock price target on competition By Investing.com

JPMorgan cut its price target on BellRing Brands to $21 from $28 while keeping an Overweight rating, citing risk to fiscal 2026 outlook and ongoing competitive pressure. The firm said second-quarter sales and EBITDA should be in line with consensus, but measured consumption rose less than the company’s 4% to 6% annual sales growth outlook. The article also notes multiple mixed analyst actions, including target raises and cuts, as well as RSU grants tied to retention during a CEO transition.

Analysis

BRBR is shifting from a clean growth de-rating story into a competition-and-guidance credibility story. The key second-order effect is that promotional intensity in ready-to-drink protein is no longer just taking share at the margin; it is likely forcing category economics lower, which can compress gross margin and reduce the value of distribution shelf space over the next 2-3 quarters. That matters because a low multiple only protects you if earnings are stable — if volume growth slows while mix weakens, the multiple can still compress further even without a dramatic top-line miss.

The most important tell is that sell-side targets are diverging because the market is no longer pricing a simple temporary slowdown; it is pricing a structural growth reset. If smaller brands and private label are training consumers to trade down on a recurring basis, BRBR could face a slower recovery even after promotional intensity normalizes, since category resets tend to leave behind a lower price ceiling and more elastic repeat behavior. That would also pressure adjacent suppliers in packaging, transport, and contract manufacturing as retailers use the category’s price elasticity to negotiate harder across the shelf.

Near term, the catalyst path is binary: a clean beat with reaffirmed FY26 guidance could trigger a sharp short-covering rally given how beaten down the stock is, but a modest guide-down would likely be punished more than usual because expectations are anchored to “stable not great.” The market is missing that the real risk is not one quarter; it is whether management’s growth algorithm still works in a promotion-driven category where share gains are getting more expensive. In that setup, the stock can look optically cheap for months while still being a value trap if consensus EPS comes down again.

The contrarian setup is that the selloff may already reflect a lot of the bad news, so the right expression is not naked shorting but timing around the print. A low-quality beat with cautious language could still be enough to drive a tradable squeeze, yet the path of least resistance afterward remains lower unless management can show measurable improvement in measured consumption versus promo spend. In other words: near-term upside is tactical, but medium-term downside persists if category share defenses keep requiring more discounting.

Key Decisions for Investors

• Trade the print tactically: buy BRBR May/June downside put spreads into earnings if implied volatility remains elevated; risk/reward favors a controlled-risk bearish expression because the post-earnings move can re-rate the stock lower on even a small guidance cut.
• If already long BRBR, trim ahead of the earnings date and re-enter only on a confirmed beat-and-raise or at least guide-maintain with evidence that consumption is outpacing promotions over the next 30-60 days.
• Pair trade: long a higher-quality staples name with pricing power versus short BRBR for 1-2 quarters; the relative value thesis is that branded defensives with stronger mix are less exposed to promo-led margin erosion.
• Use BRBR only as a tactical long if it gaps down on the print but management does not cut FY26 materially; that creates a potential 15-20% squeeze scenario, but size it small because the multi-quarter competitive trend remains adverse.
• Set a hard stop on any long exposure if management signals another step-up in promotion intensity or if fiscal Q2 consumption again trails the stated growth runway; that would imply the market is underestimating the duration of share loss.